» Articles » PMID: 28698617

Loss of MD1 Exacerbates Pressure Overload-induced Left Ventricular Structural and Electrical Remodelling

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jul 13
PMID 28698617
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloid differentiation protein 1 (MD1) has been implicated in numerous pathophysiological processes, including immune regulation, obesity, insulin resistance, and inflammation. However, the role of MD1 in cardiac remodelling remains incompletely understood. We used MD1-knockout (KO) mice and their wild-type littermates to determine the functional significance of MD1 in the regulation of aortic banding (AB)-induced left ventricular (LV) structural and electrical remodelling and its underlying mechanisms. After 4 weeks of AB, MD1-KO hearts showed substantial aggravation of LV hypertrophy, fibrosis, LV dilation and dysfunction, and electrical remodelling, which resulted in overt heart failure and increased electrophysiological instability. Moreover, MD1-KO-AB cardiomyocytes showed increased diastolic sarcoplasmic reticulum (SR) Ca leak, reduced Ca transient amplitude and SR Ca content, decreased SR Ca-ATPase2 expression, and increased phospholamban and Na/Ca-exchanger 1 protein expression. Mechanistically, the adverse effects of MD1 deletion on LV remodelling were related to hyperactivated CaMKII signalling and increased impairment of intracellular Ca homeostasis, whereas the increased electrophysiological instability was partly attributed to exaggerated prolongation of cardiac repolarisation, decreased action potential duration alternans threshold, and increased diastolic SR Ca leak. Therefore, our study on MD1 could provide new therapeutic strategies for preventing/treating heart failure.

Citing Articles

USP38 exacerbates pressure overload-induced left ventricular electrical remodeling.

Pan Y, Xiao Z, Yang H, Kong B, Meng H, Shuai W Mol Med. 2024; 30(1):97.

PMID: 38937697 PMC: 11210128. DOI: 10.1186/s10020-024-00846-3.


LY86 facilitates ox-LDL-induced lipid accumulation in macrophages by upregulating SREBP2/HMGCR expression.

Jiang G, Li J, Niu S, Dong R, Chen Y, Bi W BMC Cardiovasc Disord. 2024; 24(1):289.

PMID: 38822281 PMC: 11140969. DOI: 10.1186/s12872-024-03957-1.


Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice.

Fu H, Li D, Shuai W, Kong B, Wang X, Tang Y Mol Cell Biol. 2024; 44(4):149-163.

PMID: 38725392 PMC: 11110696. DOI: 10.1080/10985549.2024.2345363.


Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1.

Xiao Z, Dai C, Yu T, Zhu J, Pan Y, Shuai W Int J Biol Sci. 2024; 20(5):1815-1832.

PMID: 38481817 PMC: 10929191. DOI: 10.7150/ijbs.85562.


Ubiquitin-specific protease 38 promotes inflammatory atrial fibrillation induced by pressure overload.

Xiao Z, Pan Y, Kong B, Meng H, Shuai W, Huang H Europace. 2024; 26(1).

PMID: 38288617 PMC: 10823351. DOI: 10.1093/europace/euad366.


References
1.
Braunwald E . The war against heart failure: the Lancet lecture. Lancet. 2014; 385(9970):812-24. DOI: 10.1016/S0140-6736(14)61889-4. View

2.
Houser S, Margulies K, Murphy A, Spinale F, Francis G, Prabhu S . Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res. 2012; 111(1):131-50. DOI: 10.1161/RES.0b013e3182582523. View

3.
Bers D . Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. Annu Rev Physiol. 2013; 76:107-27. DOI: 10.1146/annurev-physiol-020911-153308. View

4.
Arslan F, de Kleijn D, Pasterkamp G . Innate immune signaling in cardiac ischemia. Nat Rev Cardiol. 2011; 8(5):292-300. DOI: 10.1038/nrcardio.2011.38. View

5.
Gay N, Symmons M, Gangloff M, Bryant C . Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014; 14(8):546-58. DOI: 10.1038/nri3713. View